Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules

被引:141
作者
Chesnokova, V [1 ]
Chesnokova, V [1 ]
机构
[1] Univ Calif Los Angeles, Cedars Sinai Res Inst, Sch Med, Los Angeles, CA 90048 USA
关键词
D O I
10.1210/en.143.5.1571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neuroendocrine and immune systems communicate bidirectionally. The neuro-immune-endocrine interface is mediated by cytokines acting as auto/paracrine or endocrine factors regulating pituitary development, cell proliferation, hormone secretion, and feedback control of the hypothalamic-pituitary-adrenal (HPA) axis. At birth or during neonatal ontogenesis, cytokines produce permanent alterations of HPA axis function and the stress response. Overexpressing IL-6 or leukemia inhibitory factor leads to significant changes in pituitary development and functions. Pituitary corticotroph POW gene expression is regulated by CRH as well as several gp130 cytokines acting as neuro-immuno-endocrine modulators. Conversely, HPA axis functions modulate susceptibility or resistance to inflammatory disease. Cytokines (including IL-1, TNF, and members of the gp130 cytokine family) participate as mediators of a complex HPA axis response to stress and inflammation. Prolonged exposure to proinflammatory cytokines increases levels of the dominant negative glucocorticoid receptor isoform. Nonresponsiveness of the HPA axis to glucocorticoid negative feedback control provides a defense from destructive effects of cytokine excess. At the same time, gp130 cytokines stimulate pituitary suppressor of cytokine signaling (SOCS)-3, which represses cytokine signaling and abrogates cytokine-induced corticotroph POW gene transcription and ACTH secretion.
引用
收藏
页码:1571 / 1574
页数:4
相关论文
共 53 条
  • [51] Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform:: A mechanism for the generation of glucocorticoid resistance
    Webster, JC
    Oakley, RH
    Jewell, CM
    Cidlowski, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) : 6865 - 6870
  • [52] WILDER RL, 1995, ANNU REV IMMUNOL, V13, P307
  • [53] Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: Neuro-immune-endocrine modulation of pituitary development
    Yano, H
    Readhead, C
    Nakashima, M
    Ren, SG
    Melmed, S
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (11) : 1708 - 1720